Stocks News

LAST PRICE
73.1500
TODAY'S CHANGE (%)
Trending Down-0.6600 (-0.8942%)

Bid / Lots
73.1500/ 3
Ask / Lots
74.2500/ 20
Open / Previous Close
74.5900 / 73.8100
Day Range
Low 72.9400
High 74.6300
52 Week Range
Low 21.9200
High 80.5300
Volume
1,756,992
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- DJ Insmed Is Maintained at Overweight by JP Morgan, from 14 hours ago by Dow Jones
  14 hours ago by Dow Jones
  Companies Mentioned: INSM
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/INSM/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 22, 2024 10:01 ET (15:01 GMT)
Nov 19, 2024
- Sector Update: Health Care Stocks Decline, from 4:06PM ET on Tuesday Nov 19, 2024 by MT Newswires
  4:06PM ET on Tuesday Nov 19, 2024 by MT Newswires
  Companies Mentioned: INCY, INSM, NVO, IBRX
  04:06 PM EST, 11/19/2024 (MT Newswires) -- Health care stocks fell Tuesday afternoon with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.5%. The iShares Biotechnology ETF (IBB) rose 0.3%. In corpora...
- Sector Update: Health Care Stocks Mixed Tuesday Afternoon, from 2:09PM ET on Tuesday Nov 19, 2024 by MT Newswires
  2:09PM ET on Tuesday Nov 19, 2024 by MT Newswires
  Companies Mentioned: INSM, NVO, NVNO
  02:09 PM EST, 11/19/2024 (MT Newswires) -- Health care stocks were mixed Tuesday afternoon, with the NYSE Health Care Index fractionally up and the Health Care Select Sector SPDR Fund (XLV) down 0.3%. The iShares Biotechnology ETF (IBB) rose 0.3%. I...
- Insmed Terminates $500 Million Share Sale Agreement With Leerink, from 11:47AM ET on Tuesday Nov 19, 2024 by MT Newswires
  11:47AM ET on Tuesday Nov 19, 2024 by MT Newswires
  Companies Mentioned: INSM
  11:47 AM EST, 11/19/2024 (MT Newswires) -- Insmed (INSM) said Tuesday it terminated the sale agreement with Leerink Partners, effective Monday. Under the deal, the company agreed to offer and sell up to $500 million shares from time to time through ...
Nov 7, 2024
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: INSM
  
  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  
  PR Newswire
  
  BRIDGEWATER, N.J., Nov. 7, 2024
  
  BRIDGEWATER, N.J., Nov. 7, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement awards to 27 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.

Nov 21, 2024
- Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:15PM ET on Thursday Nov 21, 2024 by Dow Jones
  4:15PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: SMMT
Nov 20, 2024
- Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm, from 2:46PM ET on Wednesday Nov 20, 2024 by Newsfile
  2:46PM ET on Wednesday Nov 20, 2024 by Newsfile
  Companies Mentioned: PCVX
- Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm, from 2:46PM ET on Wednesday Nov 20, 2024 by Dow Jones
  2:46PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: PCVX
Nov 19, 2024
- Vaxcyte Insider Sold Shares Worth $686,518, According to a Recent SEC Filing, from 4:53PM ET on Tuesday Nov 19, 2024 by MT Newswires
  4:53PM ET on Tuesday Nov 19, 2024 by MT Newswires
  Companies Mentioned: PCVX
- UBS Raises Price Target on Intra-Cellular Therapies to $87 From $79, Maintains Neutral Rating, from 10:56AM ET on Tuesday Nov 19, 2024 by MT Newswires
  10:56AM ET on Tuesday Nov 19, 2024 by MT Newswires
  Companies Mentioned: ITCI
- Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences, from 8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: ITCI
Nov 18, 2024
- DJ Summit Therapeutics Price Target Maintained With a $44.00/Share by HC Wainwright & Co., from 7:57AM ET on Monday Nov 18, 2024 by Dow Jones
  7:57AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: SMMT
Nov 15, 2024
- Intra-Cellular Therapies Insider Sold Shares Worth $3,692,100, According to a Recent SEC Filing, from 3:51AM ET on Friday Nov 15, 2024 by MT Newswires
  3:51AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: ITCI
Nov 12, 2024
- Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs, from 7:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
  7:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: PCVX
Nov 7, 2024
- DJ Revolution Medicines Is Maintained at Buy by Needham, from 3:49PM ET on Thursday Nov 07, 2024 by Dow Jones
  3:49PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: RVMD

Insmed Inc
NASDAQ:INSMUnited States

Search Criteria

Yesterday

DJ Insmed Is Maintained at Overweight by JP Morgan, from 14 hours ago by Dow Jones

Nov 19, 2024

Sector Update: Health Care Stocks Decline, from 4:06PM ET on Tuesday Nov 19, 2024 by MT Newswires

Sector Update: Health Care Stocks Mixed Tuesday Afternoon, from 2:09PM ET on Tuesday Nov 19, 2024 by MT Newswires

Insmed Terminates $500 Million Share Sale Agreement With Leerink, from 11:47AM ET on Tuesday Nov 19, 2024 by MT Newswires

Nov 7, 2024

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones

Peers Headlines

Nov 21, 2024

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:15PM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 20, 2024

Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm, from 2:46PM ET on Wednesday Nov 20, 2024 by Newsfile

Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm, from 2:46PM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 19, 2024

Vaxcyte Insider Sold Shares Worth $686,518, According to a Recent SEC Filing, from 4:53PM ET on Tuesday Nov 19, 2024 by MT Newswires

UBS Raises Price Target on Intra-Cellular Therapies to $87 From $79, Maintains Neutral Rating, from 10:56AM ET on Tuesday Nov 19, 2024 by MT Newswires

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences, from 8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 18, 2024

DJ Summit Therapeutics Price Target Maintained With a $44.00/Share by HC Wainwright & Co., from 7:57AM ET on Monday Nov 18, 2024 by Dow Jones

Nov 15, 2024

Intra-Cellular Therapies Insider Sold Shares Worth $3,692,100, According to a Recent SEC Filing, from 3:51AM ET on Friday Nov 15, 2024 by MT Newswires

Nov 12, 2024

Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs, from 7:30AM ET on Tuesday Nov 12, 2024 by Dow Jones

Nov 7, 2024

DJ Revolution Medicines Is Maintained at Buy by Needham, from 3:49PM ET on Thursday Nov 07, 2024 by Dow Jones